---
weight: 4
title: Amphetamine Cleanup with SPE Technique
authors: edited by Lenny Lin
categories: 
tags: []
description: null
draft: false
date: "2022-10-18"
lastmod: "2022-10-18"
series: 
toc: true
---

<!--more-->
---

## Sigma Aldrich: imprinted polymer SPE (SupelMIP)

### Introduction
Amphetamine and amphetamine related drugs consist of a class of stimulants and hallucinogens. In recent years, a variety of screening/detection techniques have been commercially available such as ELISA and other immuno-based colorimetric and point of collection (POC) kits/devices. Although such assays are fast and efficient, many of which are typically not class-selective and will only detect some amphetamines and not others (3). Or, some immunoassays are not selective enough and recognize such a wide range of sympathomimetic amines, the positive predictive value (PPV) can range from 0-90% (4). In either case, an alternative and highly selective class-specific confirmation assay is required to verify immuno-based screening results.

A simple, fast and class selective method is developed for trace extraction of amphetamine related drugs from urine samples using a molecularly imprinted polymer SPE (SupelMIP™) specifically designed for selective extraction of amphetamine related drugs (Figure 1). The SupelMIP technique is also compared against a recently published extraction technique using a conventional hydrophilic polymer SPE phase (5).  

When compared to a recently published conventional hydrophilic polymer SPE method, the SupelMIP method offers reduced ion-suppression and achieved lower LOQs/LODs by an order of magnitude. The highly selective SupelMIP method also offered increased recovery and reproducibility for better sensitivity, precision and accuracy.

<figure>
  <img width = "540" src = "/docs/images/the-extraction-of-a.png"/>
  <figcaption><b>Figure 1</b>. Chemical Structures of Amphetamines and Related Drugs Investigated</figcaption>
</figure>

### Extraction

<table style="width:100%; font-size: 80%">
<caption style="text-align:left", align = "top"><b>Table 1. Comparison of SupelMIP SPE – Amphetamines Method and Conventional Hydrophilic Polymer SPE Method (53228-U)</b></caption>
<colgroup><col style="width: 50%" /><col style="width: 50%" />
</colgroup>
<thead>
  <tr VALIGN=TOP style="text-align:left"  class="header">
    <th><p>SupelMIP SPE- Amphetamines Method</p></th>
    <th><p>Published Amphetamine Method Using Conventional Hydrophilic Polymer SPE Phase (5)</p></th>
  </tr>
</thead>
<tbody VALIGN=TOP>
  <tr class="odd">
    <td><p><b>Sample Pre-Treatment</b>
    </p></td>
    <td><p><b>Sample Pre-Treatment</b>
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Human urine samples were spiked with internal standard (methamphetamine-d3 and MDM A-d5) and diluted 1:1 (v/v) with 10mM ammonium acetate buffer, pH 8.
<br>Adjust to pH 7.5-8.5 using NH, or HAc
<br><b>SPE Procedure</b>
    </p></td>
    <td><p>Human urine samples were spiked with internal standard. Spiked and blank urine acidified with 100 µl 5 M HCI per 10 mL urine.
SPE Procedure
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>SupelMIP SPE - Amphetamines, 25 mg/3 mL (53228-U)
<br>1.Condition and equilibrate MIP phase with 1 mL methanol, and 1 mL 10 mM ammonium acetate buffer, pH 8
<br>2. Load 1 mL pre-treated sample on to the cartridge.
<br>3. Wash (elute interferences) using the following wash scheme:
<br>&emsp;• 2 x 1 mL DI water (Do not let column dry!)
<br>&emsp;• 1 mL 60/40 MeCN/DI water followed by 5-10 minute vacuum (-1 bar, -20 inHg, or -70 kPA) to dry the column
<br>&emsp;• 1 mL 1% HAc in MeCN
<br>4. Elute the amphetamine drugs with 2 x 1 mL 1% formic acid in methanol. Apply - 0.4 bar (-12 in Hg) between each fraction.
<br>5. Evaporate under nitrogen to dryness and reconstitute with 150µl LC mobile phase (90% A and 10% B) prior to LC-MS-MS analysis
    </p></td>
    <td><p>Conventional Hydrophilic Polymer SPE Phase, 30 mg/1 mL
<br>1. Condition and equilibrate SPE phase with 1 mL methanol and 1 mL DI water
<br>2. Load 1 mL pre-treated sample on to the cartridge.
<br>3. Wash (elute interferences) with 1 mL 5% methanol containing 2% ammonium hydroxide and with 1 mL 20% methanol containing 2% ammunium hydroxide
<br>4. Elute the amphetamine drugs with 0.5 mL 20% methanol with 2% acetic acid
<br>5. Evaporate under nitrogen and reconsitute with 150 µl LC mobile phase prior to LC-MS-MS analysis
    </p></td>
  </tr>
</tbody>
</table>

<br>
<table style="width:100%; font-size: 80%">
<caption style="text-align:left", align = "top"><b>Table 2. LC-MS-MS Conditions (581304-U)</b></caption>
<colgroup><col style="width: 30%" /><col style="width: 70%" />
</colgroup>
<tbody VALIGN=TOP>
  <tr class="odd">
    <td><p>Column:
    </p></td>
    <td><p>Ascentis C18, 15 cm x 2.1 mm, 5µm particles, (581304-U)
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Instrument:
    </p></td>
    <td><p>Shimadzu LC-20/Applied Biosystems/MDS SCIEX APl3200
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Mobile Phase:
    </p></td>
    <td><p>Solvent A - DI Water + 0.05% TFA
<br>Solvent B - Acetonitrile + 0.05% TFA
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Gradient:
    </p></td>
    <td><p>Initial: 90% A - 10% B
<br>7 min 70% A - 30% B
<br>10-11 min 10% A - 90% B
<br>11.2 min 90% A - 10% B
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Temp.:
    </p></td>
    <td><p>Ambient
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Flow Rate:
    </p></td>
    <td><p>0.2 mL/min
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Ion Mode:
    </p></td>
    <td><p>Positive
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Ion Source:
    </p></td>
    <td><p>Turbospray
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Ion Spray Voltage:
    </p></td>
    <td><p>5500V
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Source Temp.:
    </p></td>
    <td><p>600 °C
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Collision Gas:
    </p></td>
    <td><p>6 psi
    </p></td>
  </tr>
  <tr class="even">
    <td><p>Inj.:
    </p></td>
    <td><p>20 µl
    </p></td>
  </tr>
  <tr class="odd">
    <td><p>Det.:
    </p></td>
    <td><p>MS-MS
    </p></td>
  </tr>
  <tr class="even">
    <td><p>MRM transition and retention times:
    </p></td>
    <td><p>
    <table style="width:100%; font-size: 80%">
  <colgroup>
    <col style="width: 40%" /><col style="width: 20%" /><col style="width: 40%" />
  </colgroup>
  <tbody>
    <tr class="odd">
         <td VALIGN=Middle><p>Compound
         </p></td>
         <td VALIGN=TOP><p>Rt (min)
         </p></td>
         <td VALIGN=TOP><p>Q1/Q3
         </p></td>
    </tr>
    <tr class="even">
      <td><p>Amphetamine
    </p></td>
    <td><p>7.8
    </p></td>
    <td><p>136/119 and 136/91
    </p></td>
    </tr>
    <tr class="odd">
         <td VALIGN=Middle><p>Methamphetamnie
         </p></td>
         <td VALIGN=TOP><p>8.3
         </p></td>
         <td VALIGN=TOP><p>150/119 and 150/91
         </p></td>
    </tr>
    <tr class="even">
      <td><p>Methamphetamine D<sub>8</sub> 
    </p></td>
    <td><p>8.3
    </p></td>
    <td><p>158/124 and 158/93
    </p></td>
    </tr>
    <tr class="odd">
         <td VALIGN=Middle><p>Phentermine
         </p></td>
         <td VALIGN=TOP><p>8.7
         </p></td>
         <td VALIGN=TOP><p>150/133 and 150/91
         </p></td>
    </tr>
    <tr class="even">
      <td><p>MDA
    </p></td>
    <td><p>8.0
    </p></td>
    <td><p>180/163 and 180/105
    </p></td>
    </tr>
    <tr class="odd">
         <td VALIGN=Middle><p>MDMA
         </p></td>
         <td VALIGN=TOP><p>8.5
         </p></td>
         <td VALIGN=TOP><p>194/163 and 194/105
         </p></td>
    </tr>
    <tr class="even">
      <td><p>MDMA D<sub>6</sub>
    </p></td>
    <td><p>8.5
    </p></td>
    <td><p>199/165 and 199/136
    </p></td>
    </tr>
    <tr class="odd">
         <td VALIGN=Middle><p>MDEA
         </p></td>
         <td VALIGN=TOP><p>9.2
         </p></td>
         <td VALIGN=TOP><p>208/163 and108/105
         </p></td>
    </tr>
  </tbody>
</table>
    </p></td>
  </tr>
</tbody>
</table>







### Support document

**Reference**:  
1. The Combat Meth Act of 2005. Available at: . http://www.deadiversion.usdoj. gov/meth/q_a  
2. 2005. European Monitoring Centre for Drugs and Drug Addiction, Available at: .. Annual Report . . http://www.emcdda.eu.int/  
3. Walsh, Forensic Science International, 2007. In Press .  
4. Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ. 2006. Differentiation of Amphetamine/Methamphetamine and Other Cross-Immunoreactive Sympathomimetic Amines in Urine Samples by Serial Dilution Testing. 52(4):743-746. https://doi.org/10.1373/clinchem.2005.060616  
5. Fuh M, Wu T, Lin T. 2006. Determination of amphetamine and methamphetamine in urine by solid phase extraction and ion-pair liquid chromatography?electrospray?tandem mass spectrometry. Talanta. 68(3):987-991. https://doi.org/10.1016/j.talanta.2005.06.057  

**Source**: <a href = "https://www.sigmaaldrich.com/CA/en/technical-documents/technical-article/analytical-chemistry/solid-phase-extraction/the-extraction-of" target="_blank" rel="noopener noreferrer">Sigma Aldrich: The Extraction of Amphetamine and Related Drugs using Molecularly Imprinted Polymer SPE. </a>